T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
BellRing Brands
BRBR
$1.28B
| $70.8M | 0.01% |
1,198,867
-5,828
| -0.5% | -$332K |
|
627
Ivanhoe Electric
IE
$1.66B
| $70M | 0.01% |
7,146,859
-510,260
| -7% | -$4.4M |
|
628
Tenaris
TS
$26.6B
| $70M | 0.01% |
1,782,729
+56,935
| +3% | +$1.97M |
|
629
SPX Corp
SPXC
$10.6B
| $69.4M | 0.01% |
563,772
-4,390
| -0.8% | -$477K |
|
|
CRGX
630
DELISTED
CARGO Therapeutics
CRGX
| $69M | 0.01% |
3,093,347
+854,840
| +38% | +$20.3M |
|
|
EDR
631
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $68.8M | 0.01% |
2,673,608
-470,331
| -15% | -$11.5M |
|
632
PPG Industries
PPG
$25.5B
| $68.7M | 0.01% |
474,053
+3,448
| +0.7% | +$490K |
|
633
Cognex
CGNX
$10.4B
| $68.7M | 0.01% |
1,619,007
+1,469,961
| +986% | +$57.2M |
|
634
Nordson
NDSN
$17.3B
| $68M | 0.01% |
247,861
+174,330
| +237% | +$45.4M |
|
635
Lincoln Electric
LECO
$15.5B
| $68M | 0.01% |
266,098
-6,700
| -2% | -$1.58M |
|
636
Leidos
LDOS
$17.9B
| $67.8M | 0.01% |
517,498
+300,486
| +138% | +$35.8M |
|
637
Woodward
WWD
$21.2B
| $67.8M | 0.01% |
439,613
-2,648
| -0.6% | -$373K |
|
638
Lamar Advertising Co
LAMR
$15.8B
| $67.7M | 0.01% |
566,644
+22,382
| +4% | +$2.45M |
|
639
D.R. Horton
DHI
$41.9B
| $67.6M | 0.01% |
410,878
+3,069
| +0.8% | +$460K |
|
640
Sphere Entertainment
SPHR
$6.33B
| $67.5M | 0.01% |
1,375,728
-342,130
| -20% | -$13.7M |
|
641
Boyd Gaming
BYD
$6.05B
| $67.5M | 0.01% |
1,002,438
+3,087
| +0.3% | +$197K |
|
642
Atmus Filtration Technologies
ATMU
$4.06B
| $67.4M | 0.01% |
2,088,496
+583,078
| +39% | +$14M |
|
|
LPRO
643
DELISTED
Open Lending Corp
LPRO
| $67.3M | 0.01% |
10,756,601
+51,276
| +0.5% | +$378K |
|
644
Structure Therapeutics
GPCR
$3.89B
| $66.9M | 0.01% |
1,560,950
-118,486
| -7% | -$5M |
|
645
Raymond James Financial
RJF
$34.8B
| $66.8M | 0.01% |
520,492
-4,659
| -0.9% | -$543K |
|
646
Ryan Specialty Holdings
RYAN
$11B
| $66.8M | 0.01% |
1,204,254
-120,019
| -9% | -$5.73M |
|
647
EXL Service
EXLS
$5.36B
| $65.9M | 0.01% |
2,073,805
-80,092
| -4% | -$2.49M |
|
648
Cleveland-Cliffs
CLF
$6.93B
| $65.6M | 0.01% |
2,884,249
+275,265
| +11% | +$5.46M |
|
649
Sarepta Therapeutics
SRPT
$1.95B
| $65.4M | 0.01% |
504,968
-234,768
| -32% | -$28.8M |
|
650
Rambus
RMBS
$10.8B
| $65.3M | 0.01% |
1,056,350
+104,050
| +11% | +$6.58M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.